Compare AURA & TTGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AURA | TTGT |
|---|---|---|
| Founded | 2007 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 396.8M | 352.9M |
| IPO Year | 2021 | 2007 |
| Metric | AURA | TTGT |
|---|---|---|
| Price | $6.02 | $5.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $20.33 | $11.25 |
| AVG Volume (30 Days) | 211.6K | ★ 483.6K |
| Earning Date | 11-13-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $446,514,000.00 |
| Revenue This Year | N/A | $74.33 |
| Revenue Next Year | N/A | $3.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 71.55 |
| 52 Week Low | $4.35 | $4.63 |
| 52 Week High | $9.53 | $33.08 |
| Indicator | AURA | TTGT |
|---|---|---|
| Relative Strength Index (RSI) | 53.55 | 50.43 |
| Support Level | $5.31 | $4.65 |
| Resistance Level | $6.62 | $5.42 |
| Average True Range (ATR) | 0.33 | 0.30 |
| MACD | 0.10 | 0.05 |
| Stochastic Oscillator | 54.17 | 75.97 |
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
TechTarget Inc is engaged in the business-to-business (B2B) accelerator, informing and influencing technology buyers and sellers. Through its B2B first-party data and an end-to-end portfolio of data-driven solutions, it services the full B2B product lifecycle for customers from, messaging, and content development to in-market activation via brand, demand generation, purchase intent data, and sales enablement from R&D to ROI.